RISK ASSESSMENT OF HEPATOCELLULAR CARCINOMA (HCC) AND/OR LIVER RELATED COMPLICATIONS (LRC) USING FIBROSIS STAGING BY LIVER STIFFNESS MEASUREMENT (LSM) OR LIVER BIOPSY IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITH ADVANCED FIBROSIS

被引：0
|
作者：
Anancheunsook, Prooksa
Pitisuttithum, Panyavee
Chaiteerakij, Roongruedee
Komolmit, Piyawat
Treeprasertsuk, Sombat
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1510
引用
收藏
页码：S1432 / S1432
页数：1
相关论文
共 50 条
  • [21] Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
    Bernstein, David
    Kovalic, Alexander J.
    METABOLISM OPEN, 2022, 13
  • [22] Influence of liver stiffness heterogeneity on concordance of MR elastography-based liver fibrosis staging and biopsy results in patients with nonalcoholic fatty liver disease
    Nobuyoshi, K.
    Kento, I.
    Koki, N.
    Anna, O.
    Michihiro, I.
    Takashi, K.
    Asako, N.
    Yasushi, H.
    Takaomi, K.
    Yuji, O.
    Masato, Y.
    Satoru, S.
    Shinichi, A.
    Richard, E.
    Atushi, N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 104 - 105
  • [23] Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?
    Lai, Michelle
    HEPATOLOGY, 2015, 62 (04) : 997 - 998
  • [24] Noninvasive Markers of Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease (NAFLD)
    Alkhouri, Naim
    Carter-Kent, Christine A.
    Alisi, Anna
    Feldstein, Ariel E.
    Nobili, Valerio
    GASTROENTEROLOGY, 2010, 138 (05) : S453 - S453
  • [25] Feasibility and performance of the liver stiffness (LSM) measurement for the diagnosis of fibrosis in NAFLD
    Mahmoudi, A.
    Nkontchou, G.
    Lemoine, M.
    Marty, J. Reboul
    Carrie, N. Ganne
    Lemaire, V. Grando
    Trinchet, J. C.
    Beaugrand, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S354 - S355
  • [26] Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis
    Kodama, Kazuhisa
    Kawaguchi, Takumi
    Hyogo, Hideyuki
    Nakajima, Tomoaki
    Ono, Masafumi
    Seike, Masataka
    Takahashi, Hirokazu
    Nozaki, Yuichi
    Kawanaka, Miwa
    Tanaka, Saiyu
    Imajo, Kento
    Sumida, Yoshio
    Kamada, Yoshihiro
    Fujii, Hideki
    Seko, Yuya
    Takehara, Tetsuo
    Itoh, Yoshito
    Nakajima, Atsushi
    Masaki, Naohiko
    Torimura, Takuji
    Saibara, Toshiji
    Karino, Yoshiyasu
    Chayama, Kazuaki
    Tokushige, Katsutoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (09) : 1626 - 1632
  • [27] Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis
    Sangha, Kinpritma
    Chang, Stephanie T.
    Cheung, Ramsey
    Deshpande, Vibhas S.
    HEPATOLOGY, 2023, 77 (05) : 1702 - 1711
  • [28] Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis
    Harring, Michael
    Golabi, Pegah
    Paik, James M.
    Shah, Dipam
    Racila, Andrei
    Cable, Rebecca
    Srishord, Manirath
    Younossi, Zobair M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (11) : 2876 - +
  • [29] Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease
    Xu, Nan
    Xie, Qinxiu
    Li, Jiang
    Gao, Yufeng
    Li, Xu
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (02)
  • [30] MEASURES OF CARDIOMETABOLIC RISK AND ADVANCED FIBROSIS IN PRIMARY CARE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Schreiner, Andrew
    HEPATOLOGY, 2023, 78 : S1004 - S1004
12345